{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:23Z","timestamp":1792784963656,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funding in the frame of a research cooperation with IDT Biologika GmbH into mechanisms of oral rabies vaccination."},{"name":"Intramural collaborative research grant at the Friedrich-Loeffler-Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oral rabies vaccination (ORV) is highly effective in foxes and raccoon dogs, whereas for unknown reasons the efficacy of ORV in other reservoir species is less pronounced. To investigate possible variations in species-specific cell tropism and local replication of vaccine virus, different reservoir species including foxes, raccoon dogs, raccoons, mongooses, dogs and skunks were orally immunised with a highly attenuated, high-titred GFP-expressing rabies virus (RABV). Immunofluorescence and RT-qPCR screenings revealed clear differences among species suggesting host specific limitations to ORV. While for responsive species the palatine tonsils (\n                    <jats:italic>tonsilla palatina<\/jats:italic>\n                    ) were identified as a main site of virus replication, less virus dissemination was observed in the tonsils of rather refractory species. While our comparison of vaccine virus tropism emphasizes the important role that the tonsilla palatina plays in eliciting an immune response to ORV, our data also indicate that other lymphoid tissues may have a more important role than originally anticipated. Overall, these data support a model in which the susceptibility to oral live RABV vaccine infection of lymphatic tissue is a major determinant in vaccination efficacy. The present results may help to direct future research for improving vaccine uptake and efficacy of oral rabies vaccines under field conditions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-59719-4","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T06:03:30Z","timestamp":1582092210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Responsiveness of various reservoir species to oral rabies vaccination correlates with differences in vaccine uptake of mucosa associated lymphoid tissues"],"prefix":"10.1038","volume":"10","author":[{"given":"Verena","family":"te Kamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-398X","authenticated-orcid":false,"given":"Conrad M.","family":"Freuling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Nemitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Eggerbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schink\u00f6the","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-3653","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-2341","authenticated-orcid":false,"given":"Stefan","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"59719_CR1","unstructured":"Thulke, H. & Eisinger, D. The strength of 70%: revision of a standard threshold of rabies control. In Towards the elimination of rabies in Eurasia Development in Biologicals (eds B. Dodet, A. R. Fooks, T. M\u00fcller, & N. Tordo) 291\u2013298 (Karger, 2008)."},{"key":"59719_CR2","unstructured":"Aubert, M. In Wildlife Rabies Control (eds K. B\u00f6gel, F. X. Meslin, & M. Kaplan) 9\u201318 (Wells Medical Ltd., 1992)."},{"key":"59719_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tvjl.2014.10.026","volume":"203","author":"T M\u00fcller","year":"2015","unstructured":"M\u00fcller, T. et al. Terrestrial rabies control in the European Union: historical achievements and challenges ahead. Vet. J. 203, 10\u201317, https:\/\/doi.org\/10.1016\/j.tvjl.2014.10.026 (2015).","journal-title":"Vet. J."},{"key":"59719_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2460\/javma.252.8.945","volume":"252","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Rabies surveillance in the United States during 2016. J. Am. Veterinary Med. Assoc. 252, 945\u2013957, https:\/\/doi.org\/10.2460\/javma.252.8.945 (2018).","journal-title":"J. Am. Veterinary Med. Assoc."},{"key":"59719_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/clinids\/10.Supplement_4.S610","volume":"10","author":"COR Everard","year":"1988","unstructured":"Everard, C. O. R. & Everard, J. D. Mongoose Rabies. Rev. Infect. Dis. 10, 610\u2013614 (1988).","journal-title":"Rev. Infect. Dis."},{"key":"59719_CR6","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson, K. et al. Estimating the global burden of endemic canine rabies. PLOS Negl. Trop. Dis. 9, e0003709, https:\/\/doi.org\/10.1371\/journal.pntd.0003709 (2015).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"59719_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13567-018-0554-6","volume":"49","author":"F Cliquet","year":"2018","unstructured":"Cliquet, F. et al. Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination. Vet. Res. 49, 61, https:\/\/doi.org\/10.1186\/s13567-018-0554-6 (2018).","journal-title":"Vet. Res."},{"key":"59719_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2460\/javma.2005.227.785","volume":"227","author":"TJ Sidwa","year":"2005","unstructured":"Sidwa, T. J. et al. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995\u20132003. J. Am. Vet. Med. Assoc. 227, 785\u2013792 (2005).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"59719_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","volume":"37","author":"CD MacInnes","year":"2001","unstructured":"MacInnes, C. D. et al. Elimination of rabies from red foxes in eastern Ontario. J. Wildl. Dis. 37, 119\u2013132, https:\/\/doi.org\/10.7589\/0090-3558-37.1.119 (2001).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR10","doi-asserted-by":"publisher","unstructured":"Velasco-Villa, A. et al. The history of rabies in the Western Hemisphere. Antiviral Res., https:\/\/doi.org\/10.1016\/j.antiviral.2017.03.013 (2017).","DOI":"10.1016\/j.antiviral.2017.03.013"},{"key":"59719_CR11","doi-asserted-by":"publisher","first-page":"20120142","DOI":"10.1098\/rstb.2012.0142","volume":"368","author":"CM Freuling","year":"2013","unstructured":"Freuling, C. M. et al. The elimination of fox rabies from Europe: determinants of success and lessons for the future. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120142, https:\/\/doi.org\/10.1098\/rstb.2012.0142 (2013).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"59719_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13567-017-0459-9","volume":"48","author":"J Maki","year":"2017","unstructured":"Maki, J. et al. Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG((R))): a global review. Vet. Res. 48, 57, https:\/\/doi.org\/10.1186\/s13567-017-0459-9 (2017).","journal-title":"Vet. Res."},{"key":"59719_CR13","first-page":"58","volume":"52","author":"ND Tolson","year":"1988","unstructured":"Tolson, N. D., Charlton, K. M., Lawson, K. F., Campbell, J. B. & Stewart, R. B. Studies of Era\/Bhk-21 Rabies Vaccine in Skunks and Mice. Can. J. Vet. Res. 52, 58\u201362 (1988).","journal-title":"Can. J. Vet. Res."},{"key":"59719_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.7589\/0090-3558-25.4.548","volume":"25","author":"CE Rupprecht","year":"1989","unstructured":"Rupprecht, C. E., Dietzschold, B., Cox, J. H. & Schneider, L. G. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine. J. Wildl. Dis. 25, 548\u2013554, https:\/\/doi.org\/10.7589\/0090-3558-25.4.548 (1989).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR15","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","volume":"83","author":"CE Rupprecht","year":"1986","unstructured":"Rupprecht, C. E. et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl Acad. Sci. USA Biol. Sci 83, 7947\u20137950 (1986).","journal-title":"Proc. Natl Acad. Sci. USA Biol. Sci"},{"key":"59719_CR16","first-page":"178","volume":"54","author":"ND Tolson","year":"1990","unstructured":"Tolson, N. D. et al. Mutants of rabies viruses in skunks: immune response and pathogenicity. Can. J. Vet. Res. 54, 178\u2013183 (1990).","journal-title":"Can. J. Vet. Res."},{"key":"59719_CR17","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1371\/journal.pntd.0000549","volume":"3","author":"D Slate","year":"2009","unstructured":"Slate, D. et al. Oral rabies vaccination in north america: opportunities, complexities, and challenges. PLOS Negl. Trop. Dis. 3, e549, https:\/\/doi.org\/10.1371\/journal.pntd.0000549 (2009).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"59719_CR18","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.vaccine.2006.02.057","volume":"24","author":"F Cliquet","year":"2006","unstructured":"Cliquet, F. et al. Safety and efficacy of the oral rabies vaccine SAG2 in raccoon dogs. Vaccine 24, 4386\u20134392, https:\/\/doi.org\/10.1016\/j.vaccine.2006.02.057 (2006).","journal-title":"Vaccine"},{"key":"59719_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1439-0450.2001.00440.x","volume":"48","author":"A Neubert","year":"2001","unstructured":"Neubert, A., Schuster, P., M\u00fcller, T., Vos, A. & Pommerening, E. Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes. J. Vet. Med. B Infect. Dis. Public. Health. 48, 179\u2013183 (2001).","journal-title":"J. Vet. Med. B Infect. Dis. Public. Health."},{"key":"59719_CR20","first-page":"285","volume":"49","author":"P Schuster","year":"2001","unstructured":"Schuster, P. et al. Comparative immunogenicity and efficacy studies with oral rabies virus vaccine SAD P5\/88 in raccoon dogs and red foxes. Acta Vet. Hung. 49, 285\u2013290 (2001).","journal-title":"Acta Vet. Hung."},{"key":"59719_CR21","first-page":"257","volume":"131","author":"F Cliquet","year":"2008","unstructured":"Cliquet, F. et al. Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog. Dev. Biol. 131, 257\u2013264 (2008).","journal-title":"Dev. Biol."},{"key":"59719_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7589\/0090-3558-42.3.663","volume":"42","author":"JD Blanton","year":"2006","unstructured":"Blanton, J. D. et al. Vaccination of Small Asian Mongoose (Herpestes javanicus) Against Rabies. J. Wildl. Dis. 42, 663\u2013666 (2006).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7589\/2013-02-035","volume":"49","author":"A Vos","year":"2013","unstructured":"Vos, A. et al. Oral vaccination of captive small Indian mongoose (Herpestes auropunctatus) against rabies. J. Wildl. Dis. 49, 1033\u20131036, https:\/\/doi.org\/10.7589\/2013-02-035 (2013).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR24","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1016\/j.vaccine.2014.04.029","volume":"32","author":"LJ Brown","year":"2014","unstructured":"Brown, L. J. et al. Oral vaccination and protection of striped skunks (Mephitis mephitis) against rabies using ONRAB(R). Vaccine 32, 3675\u20133679, https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.029 (2014).","journal-title":"Vaccine"},{"key":"59719_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01317147","volume":"123","author":"KM Charlton","year":"1992","unstructured":"Charlton, K. M. et al. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch. Virol. 123, 169\u2013179 (1992).","journal-title":"Arch. Virol."},{"key":"59719_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7589\/0090-3558-43.1.124","volume":"43","author":"DA Grosenbaugh","year":"2007","unstructured":"Grosenbaugh, D. A., Maki, J. L., Rupprecht, C. R. & Wall, D. K. Rabies Challenge of Captive Striped Skunks (Mephitis mephitis) following Oral Administration of a Live Vaccinia-Vectored Rabies Vaccine. J. Wildl. Dis. 43, 124\u2013128 (2007).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7589\/0090-3558-26.1.99","volume":"26","author":"CE Rupprecht","year":"1990","unstructured":"Rupprecht, C. E. et al. Ineffectiveness and Comparative Pathogenicity of Attenuated Rabies Virus-Vaccines for the Striped Skunk (Mephitis-Mephitis). J. Wildl. Dis. 26, 99\u2013102 (1990).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.7589\/0090-3558-38.2.428","volume":"38","author":"A Vos","year":"2002","unstructured":"Vos, A., Pommerening, E., Neubert, L., Kachel, S. & Neubert, A. Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis). J. Wildl. Dis. 38, 428\u2013431 (2002).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0264-410X(95)00244-U","volume":"14","author":"M Fekadu","year":"1996","unstructured":"Fekadu, M. et al. Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs. Vaccine 14, 465\u2013468 (1996).","journal-title":"Vaccine"},{"key":"59719_CR30","doi-asserted-by":"crossref","unstructured":"Cliquet, F. et al. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine, 257\u2013264 (2007).","DOI":"10.1016\/j.vaccine.2006.12.054"},{"key":"59719_CR31","unstructured":"WHO. Oral immunization of dogs against rabies: report of the Sixth Consultation. (WHO, 1998)."},{"key":"59719_CR32","first-page":"93","volume":"9","author":"O Aylan","year":"1998","unstructured":"Aylan, O. & Vos, A. Efficacy studies with SAD B19 in Turkish dogs. J. ETLIK Veterinary Microbiology 9, 93\u2013102 (1998).","journal-title":"J. ETLIK Veterinary Microbiology"},{"key":"59719_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","volume":"111","author":"CE Rupprecht","year":"2005","unstructured":"Rupprecht, C. E. et al. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res. 111, 101\u2013105 (2005).","journal-title":"Virus Res."},{"key":"59719_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/oxfordjournals.aje.a112080","volume":"101","author":"GM Baer","year":"1975","unstructured":"Baer, G. M., Broderson, J. R. & Yager, P. A. Determination of the site of oral rabies vaccination. Am. J. Epidemiol. 101, 160\u2013164 (1975).","journal-title":"Am. J. Epidemiol."},{"key":"59719_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/mi.2007.9","volume":"1","author":"P Brandtzaeg","year":"2008","unstructured":"Brandtzaeg, P., Kiyono, H., Pabst, R. & Russell, M. W. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol. 1, 31\u201337, https:\/\/doi.org\/10.1038\/mi.2007.9 (2008).","journal-title":"Mucosal Immunol."},{"key":"59719_CR36","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1016\/j.vaccine.2017.06.022","volume":"35","author":"A Vos","year":"2017","unstructured":"Vos, A. et al. Oral vaccination of wildlife against rabies: Differences among host species in vaccine uptake efficiency. Vaccine 35, 3938\u20133944, https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.022 (2017).","journal-title":"Vaccine"},{"key":"59719_CR37","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","volume":"19","author":"LA Orciari","year":"2001","unstructured":"Orciari, L. A. et al. Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination. Vaccine 19, 4511\u20134518 (2001).","journal-title":"Vaccine"},{"key":"59719_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fvets.2018.00091","volume":"5","author":"S Ortmann","year":"2018","unstructured":"Ortmann, S. et al. In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies. Front. Vet. Sci. 5, 91, https:\/\/doi.org\/10.3389\/fvets.2018.00091 (2018).","journal-title":"Front. Vet. Sci."},{"key":"59719_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12917-018-1417-0","volume":"14","author":"S Ortmann","year":"2018","unstructured":"Ortmann, S. et al. Safety studies with the oral rabies virus vaccine strain SPBN GASGAS in the small Indian mongoose (Herpestes auropunctatus). BMC Vet. Res. 14, 90, https:\/\/doi.org\/10.1186\/s12917-018-1417-0 (2018).","journal-title":"BMC Vet. Res."},{"key":"59719_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7589\/0090-3558-38.2.420","volume":"38","author":"CA Hanlon","year":"2002","unstructured":"Hanlon, C. A., Niezgoda, M., Morrill, P. & Rupprecht, C. E. Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons. J. Wildl. Dis. 38, 420\u2013427 (2002).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7589\/0090-3558-27.4.681","volume":"27","author":"M Fekadu","year":"1991","unstructured":"Fekadu, M. et al. Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein. J. Wildl. Dis. 27, 681\u2013684, https:\/\/doi.org\/10.7589\/0090-3558-27.4.681 (1991).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR42","first-page":"363","volume":"51","author":"ND Tolson","year":"1987","unstructured":"Tolson, N. D., Charlton, K. M., Stewart, R. B., Campbell, J. B. & Wiktor, T. J. Immune Response in Skunks to a Vaccinia Virus Recombinant Expressing the Rabies Virus Glycoprotein. Can. J. Vet. Res. 51, 363\u2013366 (1987).","journal-title":"Can. J. Vet. Res."},{"key":"59719_CR43","first-page":"195","volume":"1012","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO expert consultation on rabies, third report. World Health Organ. Tech. Rep. Ser. 1012, 195 (2018).","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"59719_CR44","doi-asserted-by":"publisher","first-page":"472460","DOI":"10.1155\/2011\/472460","volume":"2011","author":"C Casteleyn","year":"2011","unstructured":"Casteleyn, C., Breugelmans, S., Simoens, P. & Van den Broeck, W. The tonsils revisited: review of the anatomical localization and histological characteristics of the tonsils of domestic and laboratory animals. Clin. Dev. Immunol. 2011, 472460, https:\/\/doi.org\/10.1155\/2011\/472460 (2011).","journal-title":"Clin. Dev. Immunol."},{"key":"59719_CR45","first-page":"173","volume":"119","author":"CE Rupprecht","year":"2004","unstructured":"Rupprecht, C. E., Hanlon, C. A. & Slate, D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev. Biol. 119, 173\u2013184 (2004).","journal-title":"Dev. Biol."},{"key":"59719_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/oxfordjournals.aje.a121283","volume":"93","author":"GM Baer","year":"1971","unstructured":"Baer, G. M., Abelseth, M. K. & Debbie, J. G. Oral vaccination of foxes against rabies. Am. J. Epidemiol. 93, 487\u2013490 (1971).","journal-title":"Am. J. Epidemiol."},{"key":"59719_CR47","first-page":"327","volume":"16","author":"B Brochier","year":"1985","unstructured":"Brochier, B., Godfroid, J., Costy, F., Blancou, J. & Pastoret, P. P. Vaccination of young foxes (Vulpes vulpes, L.) against rabies: trials with inactivated vaccine administered by oral and parenteral routes. Ann. Rech. Vet. 16, 327\u2013333 (1985).","journal-title":"Ann. Rech. Vet."},{"key":"59719_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7589\/0090-3558-28.4.629","volume":"28","author":"CE Rupprecht","year":"1992","unstructured":"Rupprecht, C. E., Dietzschold, B., Campbell, J. B., Charlton, K. M. & Koprowski, H. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores. J. Wildl. Dis. 28, 629\u2013635 (1992).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR49","first-page":"1","volume":"70","author":"A Vos","year":"2000","unstructured":"Vos, A., M\u00fcller, T., Schuster, P., Schl\u00fcter, H. & Neubert, A. Oral vaccination of foxes against rabies with SAD B19 in Europe, 1983 - 1998: A review. Veterinary Bull. 70, 1\u20136 (2000).","journal-title":"Veterinary Bull."},{"key":"59719_CR50","doi-asserted-by":"publisher","unstructured":"Zienius, D., Pridotkas, G., Lelesius, R. & Sereika, V. Raccoon dog rabies surveillance and post-vaccination monitoring in Lithuania 2006 to 2010. Acta Vet. Scand. 53, https:\/\/doi.org\/10.1186\/1751-0147-53-58 (2011).","DOI":"10.1186\/1751-0147-53-58"},{"key":"59719_CR51","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1016\/j.vaccine.2008.04.056","volume":"26","author":"E Niin","year":"2008","unstructured":"Niin, E., Laine, M., Guiot, A. L., Demerson, J. M. & Cliquet, F. Rabies in Estonia: Situation before and after the first campaigns of oral vaccination of wildlife with SAG2 vaccine bait. Vaccine 26, 3556\u20133565 (2008).","journal-title":"Vaccine"},{"key":"59719_CR52","doi-asserted-by":"publisher","first-page":"946","DOI":"10.7589\/0090-3558-44.4.946","volume":"44","author":"R Rosatte","year":"2008","unstructured":"Rosatte, R. et al. Prevalence of tetracycline and rabies virus antibody in raccoons, skunks, and foxes following aerial distribution of V-RG baits to control raccoon rabies in Ontario, Canada. J. Wildl. Dis. 44, 946\u2013964, https:\/\/doi.org\/10.7589\/0090-3558-44.4.946 (2008).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR53","doi-asserted-by":"publisher","unstructured":"Moore, S. et al. Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife. Trop. Med. Infect. Dis. 2, https:\/\/doi.org\/10.3390\/tropicalmed2030031 (2017).","DOI":"10.3390\/tropicalmed2030031"},{"key":"59719_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jviromet.2012.11.022","volume":"187","author":"M Wasniewski","year":"2013","unstructured":"Wasniewski, M. et al. Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field. J. Virol. Methods 187, 264\u2013270, https:\/\/doi.org\/10.1016\/j.jviromet.2012.11.022 (2013).","journal-title":"J. Virol. Methods"},{"key":"59719_CR55","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1016\/j.vaccine.2015.04.103","volume":"33","author":"C Drager","year":"2015","unstructured":"Drager, C., Petrov, A., Beer, M., Teifke, J. P. & Blome, S. Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars. Vaccine 33, 3100\u20133103, https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.103 (2015).","journal-title":"Vaccine"},{"key":"59719_CR56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.vetmic.2006.10.034","volume":"120","author":"P Koenig","year":"2007","unstructured":"Koenig, P. et al. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine. Vet. Microbiol. 120, 343\u2013351, https:\/\/doi.org\/10.1016\/j.vetmic.2006.10.034 (2007).","journal-title":"Vet. Microbiol."},{"key":"59719_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vetmic.2009.09.044","volume":"142","author":"M Tignon","year":"2010","unstructured":"Tignon, M. et al. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Vet. Microbiol. 142, 59\u201368, https:\/\/doi.org\/10.1016\/j.vetmic.2009.09.044 (2010).","journal-title":"Vet. Microbiol."},{"key":"59719_CR58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.vaccine.2017.12.076","volume":"36","author":"A Vos","year":"2018","unstructured":"Vos, A. et al. An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species. Vaccine 36, 811\u2013817, https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.076 (2018).","journal-title":"Vaccine"},{"key":"59719_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.vaccine.2007.10.072","volume":"26","author":"J Li","year":"2008","unstructured":"Li, J., McGettigan, J. P., Faber, M., Schnell, M. J. & Dietzschold, B. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 26, 419\u2013426, https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.072 (2008).","journal-title":"Vaccine"},{"key":"59719_CR60","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1128\/JVI.71.10.7372-7380.1997","volume":"71","author":"MI Thoulouze","year":"1997","unstructured":"Thoulouze, M. I., Lafage, M., Montano-Hirose, J. A. & Lafon, M. Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol. 71, 7372\u20137380 (1997).","journal-title":"J. Virol."},{"key":"59719_CR61","doi-asserted-by":"publisher","first-page":"9097","DOI":"10.1128\/JVI.00800-13","volume":"87","author":"AG Lytle","year":"2013","unstructured":"Lytle, A. G., Norton, J. E. Jr., Dorfmeier, C. L., Shen, S. & McGettigan, J. P. B cell infection and activation by rabies virus-based vaccines. J. Virol. 87, 9097\u20139110, https:\/\/doi.org\/10.1128\/JVI.00800-13 (2013).","journal-title":"J. Virol."},{"key":"59719_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/zph.12471","volume":"65","author":"A Wohlers","year":"2018","unstructured":"Wohlers, A., Lankau, E. W., Oertli, E. H. & Maki, J. Challenges to controlling rabies in skunk populations using oral rabies vaccination: A review. Zoonoses Public. Health 65, 373\u2013385, https:\/\/doi.org\/10.1111\/zph.12471 (2018).","journal-title":"Zoonoses Public. Health"},{"key":"59719_CR63","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.7589\/2011-11-331","volume":"48","author":"T Fry","year":"2012","unstructured":"Fry, T., Van Dalen, K., Hurley, J. & Nash, P. Mucosal adjuvants to improve wildlife rabies vaccination. J. Wildl. Dis. 48, 1042\u20131046, https:\/\/doi.org\/10.7589\/2011-11-331 (2012).","journal-title":"J. Wildl. Dis."},{"key":"59719_CR64","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.4049\/jimmunol.174.10.6308","volume":"174","author":"S Borsutzky","year":"2005","unstructured":"Borsutzky, S. et al. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J. Immunol. 174, 6308\u20136313 (2005).","journal-title":"J. Immunol."},{"key":"59719_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2013.10.022","volume":"173","author":"BE Benediktsdottir","year":"2014","unstructured":"Benediktsdottir, B. E., Baldursson, O. & Masson, M. Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application. J. controlled release: Off. J. Controlled Rel. Soc. 173, 18\u201331 (2014).","journal-title":"J. controlled release: Off. J. Controlled Rel. Soc."},{"key":"59719_CR66","first-page":"495","volume":"61","author":"S Sharma","year":"2006","unstructured":"Sharma, S., Kulkarni, J. & Pawar, A. P. Permeation enhancers in the transmucosal delivery of macromolecules. Pharmazie 61, 495\u2013504 (2006).","journal-title":"Pharmazie"},{"key":"59719_CR67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","volume":"175","author":"KH Conzelmann","year":"1990","unstructured":"Conzelmann, K. H., Cox, J. H., Schneider, L. G. & Thiel, H. J. Molecular Cloning and Complete Nucleotide Sequence of the Attenuated Rabies Virus SAD B19. Virology 175, 485\u2013499, https:\/\/doi.org\/10.1016\/0042-6822(90)90433-R (1990).","journal-title":"Virology"},{"key":"59719_CR68","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","volume":"13","author":"MJ Schnell","year":"1994","unstructured":"Schnell, M. J., Mebatsion, T. & Conzelmann, K. K. Infectious Rabies Viruses from Cloned Cdna. EMBO J. 13, 4195\u20134203 (1994).","journal-title":"EMBO J."},{"key":"59719_CR69","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1128\/JVI.01665-09","volume":"84","author":"S Finke","year":"2010","unstructured":"Finke, S., Granzow, H., Hurst, J., Pollin, R. & Mettenleiter, T. C. Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation. J. Virol. 84, 1816\u20131827, https:\/\/doi.org\/10.1128\/JVI.01665-09 (2010).","journal-title":"J. Virol."},{"key":"59719_CR70","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1128\/JCM.00612-10","volume":"48","author":"B Hoffmann","year":"2010","unstructured":"Hoffmann, B. et al. Improved safety for molecular diagnosis of classical rabies viruses by use of a TaqMan real-time reverse transcription-PCR \u201cdouble check\u201d strategy. J. Clin. Microbiol. 48, 3970\u20133978, https:\/\/doi.org\/10.1128\/JCM.00612-10 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"59719_CR71","first-page":"367","volume":"51","author":"WA Webster","year":"1987","unstructured":"Webster, W. A. A tissue culture infection test in routine rabies diagnosis. Can. J. Vet. Res. 51, 367\u2013369 (1987).","journal-title":"Can. J. Vet. Res."},{"key":"59719_CR72","unstructured":"Webster, W. A. & Casey, G. A. Virus isolation in neuroblastoma cell culture. In Laboratory techniques in rabies, 4th ed.; Meslin, F. X., Kaplan, M. M. & Koprowski, H., Eds. World Health Organization: Geneva, pp. 93\u2013104 (1996)."},{"key":"59719_CR73","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00705-010-0743-8","volume":"155","author":"J Orbanz","year":"2010","unstructured":"Orbanz, J. & Finke, S. Generation of recombinant European bat lyssavirus type 1 and inter-genotypic compatibility of lyssavirus genotype 1 and 5 antigenome promoters. Arch. Virol. 155, 1631\u20131641, https:\/\/doi.org\/10.1007\/s00705-010-0743-8 (2010).","journal-title":"Arch. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59719-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:04:23Z","timestamp":1670292263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59719-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59719-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737427430.793578895","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Drs A.V., P.S., C.K., A.K. and S.O. are full-time employees of Ceva Innovation Center GmbH, Germany, a company manufacturing oral rabies vaccine baits. Drs T.M., C.M.F., S.F. and V.t.K. from the Friedrich-Loeffler-Institute received funding from Ceva Innovation Center GmbH in the frame of a joint research cooperation on mechanisms of oral rabies vaccination of animals and resulting immunity but declare no other potential conflict of interest. Drs T.N., E.E., R.U. and J.S. declare no potential conflict of interest. Ceva Innovation Center GmbH, Germany, was involved in the conceptualisation, design, decision to publish, and preparation of the manuscript. The corresponding author declares no competing interest within the submission system.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2919"}}